Method for simultaneously detecting seven compounds in hericium erinaceus

Through ultra-high performance liquid chromatography-triple quadratic rod mass spectrometry combined technology, a dynamic multi-reaction monitoring method of seven compounds in Monkey Head bacteria was established, which solved the problem of difficulty in accurate detection in the existing technology, and achieved high sensitivity and high speed Selective quantitative analysis supports the quality control of monkey head bacteria-related products.

CN118978499AActive Publication Date: 2024-11-19SHANGHAI ACAD OF AGRI SCI
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202411047364.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-01
Publication Date
2024-11-19
Estimated Expiration
2044-08-01

AI Technical Summary

Technical Problem

The prior art is difficult to accurately and quantitatively detect various biologically active compounds in monkey head bacteria at the same time, affecting their application in the development of drugs and health foods.

Method used

Using ultra-high performance liquid chromatography-triple quadratic rod mass spectrometry technology, a dynamic multi-reaction monitoring method is established through the optimization of parent ions, children and collision energy, and the qualitative and quantitative analysis of seven compounds in monkey head bacteria is achieved.

Benefits of technology

Accurate targeted detection of seven compounds in Monkey Head bacteria, overcome the shortcomings of chemical methods or liquid chromatography, provide detection and analysis methods with high sensitivity and strong selectivity, and ensure the quality of Monkey Head bacteria-related products. control.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118978499A_ABST
    Figure CN118978499A_ABST
Patent Text Reader

Abstract

The invention provides three compounds erinacerine X, erinacerine Y and erinacerine Z extracted from hericium erinaceus, and also provides a method for simultaneously detecting seven compounds in hericium erinaceus, and the method comprises the following steps: (1) pretreating a hericium erinaceus sample; (2) an ultra-high performance liquid chromatography detection step; (3) obtaining mass spectrum information of the compound; (4) establishing an ultra-high performance liquid chromatography-triple quadrupole mass spectrometry combined analysis method; and (5) a data analysis step. According to the method for simultaneously detecting the seven compounds in the hericium erinaceus, accurate qualitative and quantitative analysis can be simultaneously carried out on the seven compounds generated by metabolism in hericium erinaceus mycelia and sporocarps, the sensitivity is high, the specificity is high, and therefore a rapid and accurate detection and analysis method is provided for fundamental research of the hericium erinaceus and development of related products.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of detection and analysis of effective components of edible and medicinal fungi, and in particular to a method for simultaneously detecting seven compounds in Hericium erinaceus. Background Art

[0002] Hericium erinaceus (Bull.) Pers. is a fungus of the genus Hericium. It is a traditional edible and medicinal fungus in my country. The Compendium of Materia Medica records that Hericium erinaceus has the effect of "benefiting the five internal organs and aiding digestion". With the continuous development of human science and technology, more nutritional, medicinal and health values ​​of Hericium erinaceus have been gradually verified and developed. Previously, a variety of small molecule compounds, such as alkaloids, terpenes, and pyrones, have been found in the mycelium and fruiting bodies of Hericium erinaceus. These compounds have various pharmacological activities. For example, the compounds isohericerin (formerly known as hericerin) and N-de phenylethylisohericerin have been confirmed to have α-glucosidase inhibitory activity, and isohericerin and corallocin A can enhance the production of nerve growth factor (NGF) and promote the neurite growth of N2a neuronal cells.

[0003] These compounds in Hericium erinaceus will be the material basis for the development of future blood sugar-lowering and anti-aging related drugs, health foods or functional foods. Therefore, it is necessary to establish a precise quantitative method for the simultaneous detection of these alkaloids and pyran active compounds to provide quality control standards for the development of Hericium erinaceus fruiting bodies or mycelium raw materials and future related products. Summary of the invention

[0004] The present invention first provides three compounds, erinacerin X, erinacerin Y and erinacerin Z, which are Compound 1, Compound 5 and Compound 6 as follows:

[0005]

[0006]

[0007] The above three compounds provided by the present invention are extracted and prepared from the mycelium of Hericium erinaceus, and the specific preparation method comprises the following steps:

[0008] (1) Extraction and extraction of Hericium erinaceus mycelium

[0009] The dried Hericium erinaceus mycelium is soaked and extracted with 95% by volume ethanol aqueous solution at room temperature for 3 times, each time for 24 hours, and the extracts are combined and concentrated to obtain the Hericium erinaceus mycelium alcohol extract.

[0010] The Hericium erinaceus alcohol extract was redissolved in 75% by volume ethanol aqueous solution to prepare a suspension, extracted three times with petroleum ether, the petroleum ether solutions were combined, and concentrated under reduced pressure to obtain a petroleum ether extract; the remaining part was extracted three times with ethyl acetate, the ethyl acetate solutions were combined, and concentrated under reduced pressure to obtain an ethyl acetate extract.

[0011] (2) Preparation of 7 compounds

[0012] The ethyl acetate extract was separated by medium pressure chromatography, using YMC C18 (50 μm, 12 nm) as filler, and water (A)-acetonitrile (B) gradient elution (0 min: 80% A, 20% B; 30 min: 75% A, 25% B; 36 min: 60% A, 40% B; 48 min: 55% A, 45% B; 93 min: 10% A, 90% B; 98 min: 0% A, 100% B), the flow rate was 200 ml / min, and one fraction was collected every 400 mL, and a total of 55 fractions were collected, which were numbered in the order of receipt and analyzed by thin layer chromatography. Similar fractions were combined to obtain Fr1-Fr15.

[0013] 15 components: Fr.1 (1-6, 21.46g), Fr.2 (7-12, 1.21g), Fr.3 (13-14, 0.22g), Fr.4 (15-19, 0 .34g), Fr.5(20-22, 0.33g), Fr.6(23-24, 0.58g), Fr.7(25-27, 0.76g), Fr.8(28-29 , 0.27g), Fr.9 (30-33, 0.48g), Fr.10 (34-37, 0.63g), Fr.11 (38-40, 0.72g), Fr.12 ( 41-44, 1.43g), Fr.13 (45-47, 0.56g), Fr.14 (48-49, 0.25g), Fr.15 (50-55, 0.22g).

[0014] Isolation and purification of Fr.7

[0015] Fr.7 was separated by reverse phase chromatography using a ZORBAX Eclipse Plus C18 (5μm, 21.2mm×250mm) column, an elution system of 0.01% glacial acetic acid water (A) and acetonitrile (B), an elution program of 0min: 80% A, 20% B; 60min: 70% A, 30% B, an elution flow rate of 15mL / min, a detection wavelength of 210nm, and the chromatographic peak with a retention time (RT) of about 41.853min was collected to obtain Fr.7-1.

[0016] Fr.7-1 was separated by reverse phase chromatography, the chromatographic column was ZORBAX Eclipse Plus C18 (5μm, 21.2mm×250mm), the elution system was 0.01% glacial acetic acid water (A) and acetonitrile (B), the elution procedure was isocratic elution, the elution ratio was 79% A, 21% B, the elution flow rate was 15mL / min, and the detection wavelength was 210nm. The chromatographic peak with RT of about 61.306min was collected to obtain compound 1 (4.8mg).

[0017] Isolation and purification of Fr.10

[0018] Fr.10 was separated by reverse phase chromatography using a ZORBAX Eclipse Plus C18 (5μm, 21.2mm×250mm) column, an elution system of 0.01% glacial acetic acid water (A) and acetonitrile (B), and an elution program of 0min: 63% A, 37% B; 40min: 58% A, 42% B; 45min: 58% A, 42% B. The elution flow rate was 15mL / min, the detection wavelength was 220nm, and the chromatographic peak with a RT of about 33.674min was collected to obtain Fr.10-1.

[0019] Fr.10-1 was separated by reverse phase chromatography using a ZORBAX Eclipse Plus C18 column (5 μm, 21.2 mm × 250 mm), an elution system of 0.01% glacial acetic acid water (A) and acetonitrile (B), an elution program of 0 min: 63% A, 37% B; 40 min: 60% A, 40% B, an elution flow rate of 15 mL / min, a detection wavelength of 220 nm, and a chromatographic peak with a RT of about 37.096 min was collected to obtain compound 2 (13.8 mg).

[0020] Isolation and purification of Fr.11

[0021] Fr.11 was separated by reverse phase chromatography using a ZORBAX Eclipse Plus C18 (5μm, 21.2mm×250mm) column, an elution system of 0.01% glacial acetic acid water (A) and acetonitrile (B), an elution program of 0min: 58% A, 42% B; 40min: 51% A, 49% B, an elution flow rate of 15mL / min, a detection wavelength of 220nm, and the chromatographic peak with a RT of about 37.199min was collected to obtain Fr.11-1.

[0022] Fr.11-1 was separated by gel chromatography with methanol as the eluting solvent. The same fractions were combined after TLC detection to obtain compound 3 (17.5 mg).

[0023] Isolation and purification of Fr.12

[0024] Fr.12 was separated by reverse phase chromatography using a ZORBAX Eclipse Plus C18 (5 μm, 21.2 mm × 250 mm) column. The elution system was 0.01% glacial acetic acid water (A) and acetonitrile (B). The elution procedure was 0 min: 55% A, 45% B; 50 min: 38% A, 62% B. The elution flow rate was 20 mL / min, and the detection wavelength was 201 nm. The chromatographic peak at around 22.346 min was collected to obtain compound 4 (26.8 mg), the chromatographic peak at around 40.997 min with a RT was collected to obtain compound 5 (14.1 mg), and the chromatographic peak at around 45.321 min with a RT was collected to obtain compound 6 (8.9 mg).

[0025] Isolation and purification of Fr.15

[0026] Fr.15 was recrystallized from ethanol to obtain compound 7 (33.0 mg).

[0027] The structural formulas of the above compounds 1-7 are shown in the attached Figure 1 Among them, compound 1, compound 5 and compound 6 are new compounds discovered for the first time in the present invention. Compounds 1, 5 and 6 have significant hypoglycemic effects and can be used to prepare drugs for preventing or treating diabetes, or to prepare health foods for controlling blood sugar.

[0028] The present invention also aims to provide a method for simultaneously detecting seven compounds in Hericium erinaceus, the method comprising the following steps:

[0029] (1) Pretreatment steps of Hericium erinaceus samples: adding ethanol to Hericium erinaceus fruiting bodies or mycelium for ultrasonic extraction or heating extraction at 60° C., taking the supernatant, filtering, and obtaining the filtrate as the sample solution to be tested; preparing a mixed reference solution of 7 compounds;

[0030] (2) Ultra-high performance liquid chromatography detection step: ultra-high performance liquid chromatography separation of the sample solution and the mixed reference solution of the seven compounds to obtain a better separation degree;

[0031] (3) Steps for obtaining compound mass spectrometry information: Using the mass spectrometry optimization software Agilent Optimizer, the seven compounds were scanned for parent ions, detected for daughter ion pairs, and searched for the optimal collision energy;

[0032] (4) Steps for establishing the ultra-high performance liquid chromatography-triple quadrupole mass spectrometry analysis method: In the data acquisition software Agilent MassHunter Data Acquisition, under the ultra-high performance liquid chromatography analysis conditions and triple quadrupole mass spectrometry detection conditions, the retention time, parent ion, daughter ion pair and collision energy data were imported to establish the dynamic multiple reaction monitoring (DMRM) monitoring and analysis method of the seven compounds; at the same time, the mixed reference solution and the sample solution of the seven compounds were loaded and measured;

[0033] (5) Data analysis step: using the quantitative analysis software Agilent MassHunter QuantitativeAnalysis, standard curves of seven compounds were created, the method was validated, and the sample solutions were quantitatively analyzed;

[0034] The 7 compounds described are:

[0035] Erinacerin X(C 14 H 16 O6, compound 1);

[0036] Corallocin A(C 19 H 22 O6 compound 2);

[0037] Hericerin A(C 21 H 29 NO4, compound 3);

[0038] N-de phenylethyl isohericerin(C 19 H 25 NO3, compound 4);

[0039] Erinacerin Y(C 25 H 35 NO5, compound 5);

[0040] Erinacerin Z(C 24 H 33 NO5, compound 6);

[0041] Isohericerin (C 27 H 33 NO3, compound 7);

[0042] Preferably, the pretreatment step of the Hericium erinaceus sample in step (1) is to vacuum freeze-dry the mycelium or fruiting body sample to be tested, add ethanol at a solid-liquid ratio of 1:20-40 (weight g: volume ml) (preferably 1:20), ultrasonically extract for 10-90 min or heat extract at 60° C. for 10-90 min (preferably: ultrasonic 60 min), and filter the extract with an organic phase microporous filter membrane with a pore size of 0.22 μm to obtain a sample solution to be tested;

[0043] Preferably, the preparation method of the mixed reference solution of the 7 compounds in step (1) is: accurately weigh the 7 compounds respectively, prepare a mixed standard solution with a concentration of 5 μg / mL using mass spectrometry grade methanol (wherein the concentration of each compound is 5 μg / mL), and then dilute stepwise to obtain a mixed standard working solution with concentrations of 2 μg / mL, 1 μg / mL, 500 ng / mL, 200 ng / mL, 100 ng / mL, 50 ng / mL, and 20 ng / mL of the 7 compounds, respectively;

[0044] Preferably, the chromatographic conditions for ultra-high performance liquid chromatography separation in step (2) are: Agilent ZORBAXEclipse Plus C18 chromatographic column, 1.8 μm, 2.1×150 mm, detection wavelength: 240 nm; column temperature: 35° C.; sample loading volume: 2 μL; flow rate: 0.4 mL / min; mobile phase A: 0.01% glacial acetic acid; mobile phase B: acetonitrile; elution program: 0 min: 80% A, 20% B; 12 min: 75% A, 25% B; 14 min: 63% A, 37% B; 19 min: 55% A, 45% B; 38 min: 10% A, 90% B; 40 min: 0% A, 100% B;

[0045] Preferably, the retention time, parent ion, daughter ion pair and collision energy information of each compound required for analysis in step (3) are obtained by mass spectrometry optimization software (Agilent Optimizer) as follows:

[0046] Erinacerin X(C 14 H 16 O6, compound 1): retention time: 11.65min; parent ion: 279.1; quantitative ion: 245.0, collision energy: 17; qualitative ion: 173.0, collision energy 21;

[0047] Corallocin A(C 19 H 22 O6 compound 2): retention time: 19.98min; parent ion: 345.1; quantitative ion: 300.9, collision energy: 13; qualifier ion: 121.0, collision energy 29;

[0048] Hericerin A(C 21 H 29 NO4, compound 3): retention time: 23.27min; parent ion: 358.2; quantitative ion: 274.0, collision energy: 29; qualitative ion: 219.8, collision energy 33;

[0049] N-de phenylethyl isohericerin(C 19 H 25 NO3, compound 4): retention time: 23.89min; parent ion: 314.2; quantitative ion: 229.9, collision energy: 29; qualitative ion: 175.9, collision energy 25;

[0050] Erinacerin Y(C 25 H 35 NO5, compound 5): retention time: 28.21min; parent ion: 428.2; quantitative ion: 343.9, collision energy: 37; qualitative ion: 297.9, collision energy 37;

[0051] Erinacerin Z(C 24 H 33 NO5, compound 6): retention time: 28.87min; parent ion: 414.2; quantitative ion: 340.1, collision energy: 25; qualitative ion: 256.0, collision energy 41;

[0052] Isohericerin (C 27 H 33 NO3, compound 7); retention time: 30.41min; parent ion: 418.2; quantitative ion: 334.0, collision energy: 19; qualitative ion: 280.0, collision energy 33;

[0053] Preferably, in step (4), ultra-high performance liquid chromatography-triple quadrupole mass spectrometry is used as the analytical detection instrument, wherein the chromatographic conditions of ultra-high performance liquid chromatography separation (the same as the chromatographic conditions in step (2)) are: Agilent ZORBAXEclipse Plus C18 chromatographic column, 1.8 μm, 2.1×150 mm, detection wavelength: 240 nm; column temperature: 35° C.; sample load: 2 μL; flow rate: 0.4 mL / min; mobile phase A: 0.01% glacial acetic acid; mobile phase B: acetonitrile; elution program: 0 min: 80% A, 20% B; 12 min: 75% A, 25% B; 14 min: 63% A, 37% B; 19 min: 55% A, 45% B; 38 min: 10% A, 90% B; 40 min: 0% A, 100% B; wherein the mass spectrometry conditions are: electrospray ionization source (AJS ESI) was used as the ion source, the detection was carried out in negative ion mode, the dynamic multiple reaction monitoring (DMRM) mode was selected, the capillary voltage and outlet voltage were 3500 V and 380 V, the nozzle voltage was 2000 V, the dryer temperature and flow rate were 200 °C and 16 L / min, and the sheath gas temperature and flow rate were 350 °C and 12 L / min.

[0054] The identification basis of a method for simultaneously detecting 7 compounds in Hericium erinaceus provided by the present invention is: using ultra high performance liquid chromatography-triple quadrupole mass spectrometry to detect, on the basis of qualitative identification of compounds by retention time, further qualitative and quantitative analysis is performed according to the molecular ion information of the compounds, and the compounds are accurately targeted for detection.

[0055] Ultra-high performance liquid chromatography-triple quadrupole mass spectrometry technology can accurately detect compounds qualitatively and quantitatively not only through retention time, but also from mass spectral information such as parent ions and daughter ions. Therefore, the present invention uses ultra-high performance liquid chromatography-triple quadrupole mass spectrometry to establish a method for simultaneously detecting 7 compounds in the mycelium or fruiting body of Hericium erinaceus. Quantitative analysis is achieved when there are many impurities interfering in biological materials and the target compound has similar structures.

[0056] The beneficial effects of the present invention are as follows: the technical solution of the present invention combines the high separation ability of liquid chromatography and the function of mass spectrometry to provide structural information, can obtain rich and effective compound structural information, has the advantages of high sensitivity and strong selectivity, can effectively overcome the shortcomings of chemical methods or liquid chromatography, and thus provide accurate and reliable detection and analysis methods for Hericium erinaceus related research and products. BRIEF DESCRIPTION OF THE DRAWINGS

[0057] Figure 1 、Structural formulas of 7 compounds of Hericium erinaceus

[0058] Figure 2 DMRM acquisition diagram of 7 compounds of Hericium erinaceus

[0059] Among them, compound 1: Erinacerin X;

[0060] Compound 2: Corallocin A;

[0061] Compound 3: Hericerin A;

[0062] Compound 4: N-de phenylethyl isohericerin;

[0063] Compound 5: Erincerin Y;

[0064] Compound 6: Erinacerin Z;

[0065] Compound 7: Isohericerin; DETAILED DESCRIPTION

[0066] The technical solution of the present invention is further illustrated by specific embodiments below, but it is not intended to limit the solution of the present invention, and the protection scope of the present invention cannot be limited by it. All equivalent changes and modifications made according to the scope of the patent application of the present invention should fall within the scope of the present invention.

[0067] Unless otherwise specified, the experimental methods used in the following examples are conventional methods.

[0068] Unless otherwise specified, the materials and reagents used in the following examples can be obtained from commercial sources.

[0069] Glucose potato agar (PDA): purchased from Beijing Solebow Technology Co., Ltd.;

[0070] Glucose, soluble starch, yeast, MgSO4·H2O, KH2PO4, CaSO4, and analytical grade ethanol, chloroform, petroleum ether, acetone, ethanol, ethanol, acetonitrile, and glacial acetic acid were purchased from Sinopharm Chemical Reagent Co., Ltd.;

[0071] α-Glucosidase (33.7 U / mg) and acarbose were purchased from Shanghai Yuanye Biotechnology Co., Ltd.;

[0072] Phosphate buffered saline (PBS), dimethyl sulfoxide (DMSO): purchased from Sigma Chemical Company, USA;

[0073] 4-Nitrophenyl-α-D-pyranoglucoside (PNPG): purchased from TCI (Shanghai) Chemical Industry Development Company

[0074] Chromatographic grade methanol and acetonitrile: purchased from Shanghai Anpu Laboratory Technology Co., Ltd.;

[0075] Deuterated chloroform: purchased from Sigma;

[0076] YMC*GEL C18 silica gel (50μm, 12nm): YMC Company, Japan;

[0077] Sephadex LH-20 gel (70 μm): GE, USA;

[0078] Zorbax Eclipse Plus C18 analytical column (1.8 μm, 2.1 × 150 mm): Agilent, USA;

[0079] Zorbax Eclipse Plus-C18 semi-preparative column (5 μm, 21.2 mm × 250 mm): Agilent, USA;

[0080] C-605-620-660 medium pressure preparative chromatography: Switzerland company;

[0081] LC3000 medium and high pressure preparative chromatography: Beijing Chuangxin Tongheng Technology Co., Ltd.;

[0082] Agilent LC1290 infinity II ultra-high performance liquid chromatograph: Agilent, USA;

[0083] Agilent 6495 triple quadrupole mass spectrometer: Agilent, USA;

[0084] Bruker AV II-600 NMR spectrometer: Bruker, Germany;

[0085] Synergy HT multifunctional microplate reader: BIO-TEK, USA;

[0086] Thermo Scientific Q Exactive HF Orbitrap-FTMS high-resolution mass spectrometer: Thermo Corporation, USA

[0087] Source of Hericium erinaceus mycelium: Strain 1: Hericium erinaceus, strain number: 7080, the strain is currently preserved in the National Edible Fungi Germplasm Resource Bank (Shanghai).

[0088] Example 1 Hericium erinaceus mycelium fermentation

[0089] Culture medium formula: soluble starch 3%, glucose 1.2%, yeast 3%, MgSO4·7H2O 0.20%, KH2PO4 0.20% (all the above are weight percentages), water balance, natural pH.

[0090] The strain (strain 1) stored on PDA medium in a 4°C refrigerator was activated and cultured in a shake flask under primary shaking conditions for 7 days (150 r / min, 26°C) in the dark, transferred to a secondary shake flask at a 10% inoculum and cultured for 7 days (150 r / min, 26°C), and then transferred to static culture for 21 days to obtain mycelium.

[0091] Example 2 Preparation of 7 compounds

[0092] (1) Extraction and extraction of Hericium erinaceus mycelium

[0093] The dried mycelium (strain 1) obtained by fermentation in Example 1 was soaked and extracted with a 95% ethanol aqueous solution at room temperature for 3 times, each time for 24 hours, and the extracts were combined and concentrated to obtain an alcohol extract of Hericium erinaceus mycelium.

[0094] The Hericium erinaceus alcohol extract was redissolved in 75% ethanol aqueous solution to prepare a suspension, extracted with petroleum ether for three times, the petroleum ether solutions were combined, and concentrated under reduced pressure to obtain a petroleum ether extract; the remaining part was extracted with ethyl acetate for three times, the ethyl acetate solutions were combined, and concentrated under reduced pressure to obtain an ethyl acetate extract.

[0095] (2) Preparation of 7 compounds

[0096] The ethyl acetate extract was separated by medium pressure chromatography using YMC C18 (50 μm, 12 nm) as filler and water (A)-acetonitrile (B) gradient elution (0 min: 80% A, 20% B; 30 min: 75% A, 25% B; 36 min:

[0097] 60% A, 40% B; 48min: 55% A, 45% B; 93min: 10% A, 90% B; 98min: 0% A, 100% B), the flow rate was 200ml / min, one fraction was collected every 400mL, a total of 55 fractions were collected, numbered according to the order of receipt and analyzed by thin layer chromatography. Similar fractions were combined to obtain Fr1-Fr15.

[0098] 15 components: Fr.1 (1-6, 21.46g), Fr.2 (7-12, 1.21g), Fr.3 (13-14, 0.22g), Fr.4 (15-19, 0 .34g), Fr.5(20-22, 0.33g), Fr.6(23-24, 0.58g), Fr.7(25-27, 0.76g), Fr.8(28-29 , 0.27g), Fr.9 (30-33, 0.48g), Fr.10 (34-37, 0.63g), Fr.11 (38-40, 0.72g), Fr.12 ( 41-44, 1.43g), Fr.13 (45-47, 0.56g), Fr.14 (48-49, 0.25g), Fr.15 (50-55, 0.22g).

[0099] Isolation and purification of Fr.7

[0100] Fr.7 was separated by reverse phase chromatography using a ZORBAX Eclipse Plus C18 (5μm, 21.2mm×250mm) column, an elution system of 0.01% glacial acetic acid water (A) and acetonitrile (B), an elution program of 0min: 80% A, 20% B; 60min: 70% A, 30% B, an elution flow rate of 15mL / min, a detection wavelength of 210nm, and the chromatographic peak with a retention time (RT) of about 41.853min was collected to obtain Fr.7-1.

[0101] Fr.7-1 was separated by reverse phase chromatography, the chromatographic column was ZORBAX Eclipse Plus C18 (5μm, 21.2mm×250mm), the elution system was 0.01% glacial acetic acid water (A) and acetonitrile (B), the elution procedure was isocratic elution, the elution ratio was 79% A, 21% B, the elution flow rate was 15mL / min, and the detection wavelength was 210nm. The chromatographic peak with RT of about 61.306min was collected to obtain compound 1 (4.8mg).

[0102] Isolation and purification of Fr.10

[0103] Fr.10 was separated by reverse phase chromatography using a ZORBAX Eclipse Plus C18 (5μm, 21.2mm×250mm) column, an elution system of 0.01% glacial acetic acid water (A) and acetonitrile (B), and an elution program of 0min: 63% A, 37% B; 40min: 58% A, 42% B; 45min: 58% A, 42% B. The elution flow rate was 15mL / min, the detection wavelength was 220nm, and the chromatographic peak with a RT of about 33.674min was collected to obtain Fr.10-1.

[0104] Fr.10-1 was separated by reverse phase chromatography using a ZORBAX Eclipse Plus C18 column (5 μm, 21.2 mm × 250 mm), an elution system of 0.01% glacial acetic acid water (A) and acetonitrile (B), an elution program of 0 min: 63% A, 37% B; 40 min: 60% A, 40% B, an elution flow rate of 15 mL / min, a detection wavelength of 220 nm, and a chromatographic peak with a RT of about 37.096 min was collected to obtain compound 2 (13.8 mg).

[0105] Isolation and purification of Fr.11

[0106] Fr.11 was separated by reverse phase chromatography using a ZORBAX Eclipse Plus C18 (5μm, 21.2mm×250mm) column, an elution system of 0.01% glacial acetic acid water (A) and acetonitrile (B), an elution program of 0min: 58% A, 42% B; 40min: 51% A, 49% B, an elution flow rate of 15mL / min, a detection wavelength of 220nm, and the chromatographic peak with a RT of about 37.199min was collected to obtain Fr.11-1.

[0107] Fr.11-1 was separated by gel chromatography with methanol as the eluting solvent. The same fractions were combined after TLC detection to obtain compound 3 (17.5 mg).

[0108] Isolation and purification of Fr.12

[0109] Fr.12 was separated by reverse phase chromatography using a ZORBAX Eclipse Plus C18 (5 μm, 21.2 mm × 250 mm) column. The elution system was 0.01% glacial acetic acid water (A) and acetonitrile (B). The elution procedure was 0 min: 55% A, 45% B; 50 min: 38% A, 62% B. The elution flow rate was 20 mL / min, and the detection wavelength was 201 nm. The chromatographic peak at around 22.346 min was collected to obtain compound 4 (26.8 mg), the chromatographic peak at around 40.997 min with a RT was collected to obtain compound 5 (14.1 mg), and the chromatographic peak at around 45.321 min with a RT was collected to obtain compound 6 (8.9 mg).

[0110] Isolation and purification of Fr.15

[0111] Fr.15 was recrystallized from ethanol to obtain compound 7 (33.0 mg).

[0112] (3) Confirmation of Compounds 1-7.

[0113] Using mass spectrometry and nuclear magnetic resonance detection, the seven compounds obtained from Hericium erinaceus mycelium were structurally analyzed to determine their precise chemical structures. The specific confirmation information of the seven compounds is as follows:

[0114] Compound 1erinacerin X

[0115] The molecular formula is C 14 H 16 O6, white amorphous powder, easily soluble in chloroform and methanol. HRESIMS m / z: 279.0876 [MH] - (C 14 H 15 O6, calculated value 279.0874). 13 C-NMR(CDCl3,125MHz)δ:182.3(C-4'),172.3(C-1),159.6(C-6),150.2(C-4),127.7(C-3a),125.1(C-7a) ,122.2(C-5),98.1(C-7),68.5(C-3),56.2(C-OCH3),38.5(C-3'),32.0(C-2'),21.3(C-1'),17.6(C-5'); 1 H-NMR(CDCl3,500MHz)δ:6.94(1H,s,H-7),5.25(1H,s,H-3),3.86(3H,s,H-OCH3),2.80(1H,m, H-1'), 2.69 (1H, m, H-1'), 2.56 (1H, m, H-3'), 1.78 (1H, m, H-2'), 1.26d (1H, d, J = 10.0Hz, H-5').

[0116] Compound 2corallocin A

[0117] The molecular formula is C 19 H 22 O6, light yellow oil, easily soluble in methanol. ESI positive ion mode m / z: 369.0

[0118] [M+Na] + . 13C-NMR(CDCl3,125MHz)δ:172.9C-8'),172.4(C-1),159.3(C-6),149.9(C-4),144.39(C-6'),137.09(C-3'),127.5(C-7'),127.3(C-3a),124.8 (C-7a),122.4(C-5),122.3(C-2'),98.6(C-7),68.4(C-3),56.2(C-OCH 3),38.1(C-4'),26.89(C-5'),22.9(C-1'),16.1(C-9'),12.3(C-10'); 1 H-NMR(CDCl3,500MHz)δ:6.92(1H,s,H-7),6.77(1H,t,J=5.0Hz,H-6'),5.22(1H,m,H-2'),5.21(1H,s,H-3),3.85(3H,s,H- OCH3),3.47(1H,d,J=5.0Hz,H-1'),2.33(1H,m,H-5'),2.19(1H,t,J=5.0Hz,H-4'),1.80(1H,s,H-9'),1.78(1H,s,H-10').

[0119] Compound 3hericerin A

[0120] The molecular formula is C 21 H 29 NO4, light yellow amorphous powder, easily soluble in chloroform and methanol. ESI positive ion mode m / z: 360.2 [M+H] + . 13 C-NMR(CDCl3,125MHz)δ:170.5(C-1),158.7(C-6),150.4(C-4),138.7(C-3' ),132.1(C-7'),131.5(C-3a),123.9(C-6'),121.5(C-7a),121.4(C-2'),119 .6(C-5),97.5(C-7),61.4(C-2”),56.1(C-OCH3),49.4(C-3),46.2(C-1”),39 .9(C-4'),26.5(C-5'),25.8(C-8'),22.9(C-1'),17.8(C-10'),16.3(C-9'); 1H-NMR (CDCl3, 500MHz) δ: 6.89 (1H, s, H-7), 5.22 (1H, t, J = 5.0 Hz, H-2'), 5.04 (1H, t, J =5.0Hz,H-6'),4.39(1H,s,H-3),3.86(1H,t,J=5.0Hz,H-2”),3.81(3H,s,H-OCH3),3. 71(1H,t,J=5.0Hz,H-1”),3.46(1H,d,J=5.0Hz,H-1’),2.09(1H,m,H-5’),2.05(1H,m ,H-5'),2.04(1H,m,H-4'),1.80(1H,s,H-9'),1.66(1H,s,H-8'),1.58(1H,s,H-10').

[0121] Compound 4N-de phenylethyl isohericerin

[0122] The molecular formula is C 19 H 25 NO3, colorless amorphous powder, easily soluble in chloroform and methanol. ESI positive ion mode m / z: 316.0 [M+H] + . 13 C-NMR (CDCl3, 125MHz) δ: 169.2 (C-1), 158.5 (C-6), 150.7 (C-4), 140.0 (C-3'), 132.4 (C-7'), 132.2 (C-3a), 123.7 (C-6'), 121.2 (C-7a), 121. 2(C-2'),118.4(C-5),97.8(C-7),56.3(C-OCH3),47.7(C-3),39.8(C- 4'),26.4(C-5'),25.9(C-8'),22.9(C-1'),17.9(C-10'),16.3(C-9'); 1 H-NMR(CDCl3,500MHz)δ:6.97(1H,s,H-7),5.25(1H,t,J=5.0Hz,H-2'),5.04(1H,t,J=5.0Hz,H-6'),4.34(1H,s,H-3),3.86(3H,s,H-OCH3),3. 50(1H,d,J=5.0Hz,H-1'),2.11(1H,m,H-5'),2.09(1H,m,H-4'),2.09( 1H,m,H-5'),1.82(1H,s,H-9'),1.67(1H,s,H-8'),1.59(1H,s,H-10').

[0123] Compound 5erinacerin Y

[0124] The molecular formula is C 25 H 35 NO5, light yellow oil, easily soluble in chloroform and methanol. HRESIMS m / z: 452.2404 [M+Na] + (C 25 H 35 NO5Na, calculated value 452.2407). 13 C-NMR(CDCl3,125MHz)δ:173.3(C-4”),169.2(C-1),158.5(C-6),150.7(C-4),140.0(C-3' ),132.4(C-7'),132.2(C-3a),123.7(C-6'),121.2(C-7a),121.2(C-2'),118.4(C-5),97. 8(C-7),60.7(C-5”),56.3(C-OCH3),47.7(C-3),42.0(C-1”),39.8(C-4’),31.6(C-3”),26 .4(C-5'),25.9(C-8'),23.9(C-2”),22.9(C-1’),17.9(C-10’),16.3(C-9’),14.3(C-6”); 1 H-NMR(CDCl3,500MHz)δ:6.97(1H,s,H-7),5.25(1H,t,J=12.0Hz,H-2'),5.03(1H,t,J=6.0Hz,H-6'),4.28(1H,s ,H-3),4.09(1H,dd,J=6.0,12.0Hz,H-5”),3.86(3H,s,H-OCH3),3.64(1H,t,J=12.0Hz,H-1”),3.49(1H,d,J=12. 0Hz,H-1'),2.37(1H,t,J=6.0Hz,H-3"),2.12(1H,m,H-5'),2.09(1H,t,J=6.0Hz,H-4'),2.09(1H,m,H-5'),2.00 (1H,t,J=12.0Hz,H-2"),1.81(1H,s,H-9'),1.66(1H,s,H-8'),1.58(1H,s,H-10'),1.23(1H,t,J=6.0Hz,H-6").

[0125] Compound 6erinacerin Z

[0126] The molecular formula is C 24 H 33NO5, light yellow oil, easily soluble in chloroform and methanol. HRESIMS m / z: 438.2240 [M+Na] + (C 24 H 33 NO5Na, calculated value 438.2251). 13 C-NMR (CDCl3, 125MHz)δ:

[0127] 172.0(C-2”),169.2(C-1),158.5(C-6),150.6(C-4),140.0(C-3’),132.5(C-7’),131.7(C-3a),

[0128] 123.7(C-6'),121.9(C-7a),121.1(C-2'),118.6(C-5),97.9(C-7),61.5(C-3”),56.3(C-OCH3),49.5(C-1”),44. 5(C-3),39.8(C-4'),26.4(C-5'),25.9(C-8'),22.9(C-1'),17.9(C-10'),16.4(C-9'),16.0(C-1”),14.3(C-4”); 1 H-NMR(CDCl3,500MHz)δ:6.97(1H,s,H-7),5.25(1H,t,J=6.0Hz,H-2'),5.15(1H,m,H -1"),5.04(1H,t,J=6.0Hz,H-6'),4.44(1H,d,J=12.0Hz,H-3),4.30(1H,d,J=18.0Hz ,H-3),4.18(1H,dd,J=6.0,12.0Hz,H-3”),3.86(3H,s,H-OCH3),3.49(1H,d,J=6.0Hz ,H-1'),2.12(1H,m,H-5'),2.09(1H,m,H-4'),2.09(1H,m,H-5'),1.83(1H,s,H-9'),

[0129] 1.68(1H,s,H-8'), 1.60(1H,s,H-10'), 1.56(1H,d,J=12.0Hz,H-5”), 1.26(1H,t,J=6.0Hz,H-4”).

[0130] Compound 7isohericerin

[0131] The molecular formula is C 27 H 33NO3, colorless amorphous powder, easily soluble in chloroform and methanol. ESI positive ion mode m / z: 442.0 [M+Na] + . 13 C-NMR(CDCl3,125MHz)δ:169.0(C-1),158.5(C-6),150.7(C-4),139.7(C-3”),138.9(C-3’), 132.4(C-7'),132.3(C-3a),128.8(C-4”,8”),128.7(C-5”,7”),126.6(C-6”),123.8(C-6’), 121.3(C-2'),121.2(C-7a),118.4(C-5),97.7(C-7),56.2(C-OCH3),48.2(C-3),44.4(C-1”) ,39.8(C-4'),35.0(C-2”),26.4(C-5’),25.9(C-8’),22.9(C-1’),17.9(C-10’),16.3(C-9’); 1 H-NMR(CDCl3,500MHz)δ:7.27(1H,m,H-6”),7.26(1H,m,H-5”,7”),7.22(1H,m,H-4”,8”),6.96(1H,s ,H-7),5.24(1H,t,J=10.0Hz,H-2'),5.03(1H,t,J=5.0Hz,H-6'),4.15(1H,s,H-3),3.85(1H,t,J=10 .0Hz,H-1”),3.84(3H,s,H-OCH3),3.49(1H,d,J=10.0Hz,H-1’),2.97(1H,t,J=10.0Hz,H-2”),2.10( 1H,m,H-5'),2.08(1H,t,J=5.0Hz,H-4'),1.81(1H,s,H-9'),1.66(1H,s,H-8'),1.58(1H,s,H-10').

[0132] Example 3 Verification of the hypoglycemic activity of the compound in vitro

[0133] After the seven compounds were accurately weighed, they were prepared into 2000 μM sample solutions with DMSO, and then diluted step by step into 1000 μM, 500 μM, 200 μM and 100 μM sample solutions.

[0134] Sample group: 20 μL of sample solutions of different concentrations were added to the 96-well plate, and then 180 μL PBS and 25 μL α-glucosidase solution (0.2 U / mL) were added to each well, mixed well and placed at room temperature for 10 minutes. Then 25 μL PNPG (23.2 mM PBS solution) was added and reacted at 37°C for 15 minutes. After the reaction was completed, the absorbance of each well was detected at 405 nm.

[0135] Positive control group: replace the sample solution in the sample group with acarbose solution. Preparation method of acarbose solution: accurately weigh acarbose and dissolve it in DMSO to obtain a 10000 μM acarbose solution, and then dilute it with DMSO in order to 2000 μM, 1000 μM, 500 μM, 100 μM, 10 μM, 1 μM, and 0.5 μM acarbose solution.

[0136] Blank group: 20 μL DMSO was used to replace the sample solution in the sample group.

[0137] The background groups include a blank background group, a sample background group and an acarbose background group, and all background groups use 25 μL of PBS solution to replace the α-glucosidase solution. For example, the blank background group uses 25 μL of PBS solution to replace the α-glucosidase solution in the blank group.

[0138]

[0139] Experimental results:

[0140] Among the 7 compounds, compounds 2 (corallocins A), 4 (N-de phenylethyl isohericerin), 5 (erinacerin Y), 6 (erinacerin Z), and 7 (isohericerin) showed strong inhibitory activity against α-glucosidase. Among them, compound 7 had the strongest inhibitory ability, with an IC 50 The value is 19.8μM. The inhibitory ability of compounds 4, 6, 5, and 2 decreases in turn, and the IC 50 The values ​​were 31.29 μM, 31.73 μM, 40.08 μM, and 76.49 μM, respectively. The activities of compounds 1 (erinacerin X) and 3 (hericerin A) were relatively poor, and at the highest concentration (160 μM) of the experiment, their inhibition rates on α-glucosidase were less than 50%.

[0141] Example 4 Establishment of detection method

[0142] Preparation of mixed reference solution: Take the 7 reference substances of the compounds prepared in Example 2, prepare them into a mixed standard solution with a concentration of 5 μg / mL with mass spectrometry grade methanol (wherein the concentration of each reference substance is 5 μg / mL), and dilute them step by step with mass spectrometry grade methanol to mixed reference solutions with concentrations of 2 μg / mL, 1 μg / mL, 500 ng / mL, 200 ng / mL, 100 ng / mL, 50 ng / mL, and 20 ng / mL, respectively, and place them in a 4°C refrigerator for use.

[0143] Ultra-high performance liquid chromatography detection steps: Optimize the ultra-high performance liquid chromatography elution conditions of the mixed solution of the seven compound reference substances to obtain the best separation degree;

[0144] Among them, the ultra-high performance liquid phase conditions are: Agilent ZORBAX Eclipse Plμs C18 chromatographic column, 1.8μm, 2.1×150mm, detection wavelength: 240nm; column temperature: 35℃; sample volume is 2μL; flow rate: 0.4mL / min; mobile phase A: 0.01% formic acid; mobile phase B: acetonitrile; elution program: 0min: 80% A, 20% B; 12min: 75% A, 25% B; 14min: 63% A, 37% B; 19min: 55% A, 45% B; 38min: 10% A, 90% B; 40min: 0% A, 100% B.

[0145] Steps for obtaining compound mass spectrometry information: 7 compound reference substances were prepared into 10 ppm methanol solutions respectively, and the parent ion information of the 7 compounds was confirmed in negative ion mode. Then, the Agilent Optimizer software was used to automatically optimize the daughter ions and collision energy after confirming the parent ions.

[0146] Compound 1: retention time: 11.65min; parent ion: 279.1; quantitative ion: 245.0, collision energy: 17; qualifier ion: 173.0, collision energy 21;

[0147] Compound 2: retention time: 19.98min; parent ion: 345.1; quantitative ion: 300.9, collision energy: 13; qualifier ion: 121.0, collision energy 29;

[0148] Compound 3: retention time: 23.27min; parent ion: 358.2; quantitative ion: 274.0, collision energy: 29; qualifier ion: 219.8, collision energy 33;

[0149] Compound 4: retention time: 23.89min; parent ion: 314.2; quantitative ion: 229.9, collision energy: 29; qualifier ion: 175.9, collision energy 25;

[0150] Compound 5: retention time: 28.21min; parent ion: 428.2; quantitative ion: 343.9, collision energy: 37; qualifier ion: 297.9, collision energy 37;

[0151] Compound 6: retention time: 28.87min; parent ion: 414.2; quantitative ion: 340.1, collision energy: 25; qualifier ion: 256.0, collision energy 41;

[0152] Compound 7; retention time: 30.41min; parent ion: 418.2; quantitative ion: 334.0, collision energy: 19; qualifier ion: 280.0, collision energy 33;

[0153] Establishment of the quantitative analysis method using ultra-high performance liquid chromatography-triple quadrupole mass spectrometry: Under the ultra-high performance liquid chromatography and triple quadrupole mass spectrometry parameter settings in the data acquisition software (Agilent MassHμnter Data Acqμisition), the mass spectrometry acquisition mode was changed to multiple reaction monitoring (MRM), and then the parent ion information, quantitative and qualitative daughter ion pair information, collision energy and other information of the compound were imported into the detection method. A mixed reference solution of 7 compounds was sampled, and after running the program, the acquisition mode was updated to dynamic multiple reaction monitoring (DMRM).

[0154] Among them, the chromatographic conditions for ultra-high performance liquid chromatography separation are: Agilent ZORBAX Eclipse PlμsC18 chromatographic column, 1.8μm, 2.1×150mm, detection wavelength: 240nm; column temperature: 35°C; sample volume: 2μL; flow rate: 0.4mL / min; mobile phase A: 0.01% formic acid; mobile phase B: acetonitrile; elution program: 0min: 80% A, 20% B; 12min: 75% A, 25% B; 14min: 63% A, 37% B; 19min: 55% A, 45% B; 38min: 10% A, 90% B; 40min: 0% A, 100% B.

[0155] Among them, the triple quadrupole mass spectrometry analysis conditions were: electrospray ionization source AJS ESI was used as the ion source, detection was carried out in negative ion mode, dynamic multiple reaction monitoring DMRM was selected, the capillary voltage and outlet voltage were 3500 V and 380 V respectively, the nozzle voltage was 2000 V, the dryer temperature and flow rate were 200 °C and 16 L / min respectively, and the sheath gas temperature and flow rate were 350 °C and 12 L / min respectively.

[0156] Limit of detection and limit of quantification: The limit of detection (LOD) and limit of quantification (LOQ) are calculated based on the standard deviation of the response value and the slope of the standard curve. Where: LOD = 3σ / S, LOQ = 10σ / S, σ: standard deviation of the response value, S: slope of the standard curve, and the standard deviation of the response value is the residual standard deviation of the standard curve.

[0157] Preparation of standard curve: Take the prepared mixed reference solution of 5μg / mL, 2μg / mL, 1μg / mL, 500ng / mL, 200ng / mL, 100ng / mL, 50ng / mL, and 20ng / mL and load it according to the 4 optimized HPLC separation conditions and triple quadrupole mass spectrometry analysis conditions in the above steps. The horizontal axis is the concentration of the compound and the vertical axis is the quantitative ion response value of the compound. The quantitative standard curve equation is shown in Table 1.

[0158] Table 1. Linear range, linear equation, correlation coefficient, detection limit and quantification limit of 7 compounds

[0159]

[0160] Example 5 Verification of the detection method of Example 4

[0161] The methodological validation refers to the laboratory quality control specifications, food physical and chemical testing standards and relevant provisions of the pharmacopoeia.

[0162] Precision: Take the mixed reference solution and repeat the injection 6 times on the same day. Calculate the concentration of 7 compounds obtained from 6 experiments according to the standard curve to calculate the intra-day precision. Take the mixed reference solution for three consecutive days and inject it 3 times a day. Calculate the inter-day precision according to the results of 9 experiments. The results show that the RSDs of the intra-day precision determination results of the 7 compounds are 0.53%, 0.81%, 0.82%, 0.98%, 0.40%, 0.54%, and 0.7%, respectively; the RSDs of the inter-day precision determination results are 1.35%, 2.07%, 2.13%, 1.82%, 1.56%, 1.84%, and 1.25%, respectively, all less than 15.00%, indicating that the intra-day and inter-day precision of this method are good. See Tables 2 and 3 for specific results.

[0163] Stability: Take the dried mycelium of strain 1, extract according to the steps in Example 1, and inject the sample solution at 0h, 2h, 4h, 6h, 8h, 12h, and 24h, respectively, and calculate the sample stability based on the results of 7 experiments. The results show that the RSDs of the 7 compounds are 2.86%, 0.60%, 1.23%, 0.93%, 1.64%, 0.81%, and 0.82%, respectively, all less than 15.00%, indicating that the sample test results are stable within 24 hours. The specific results are shown in Table 4.

[0164] Repeatability: 6 portions of dried mycelium of strain 1 were weighed in parallel, and after being processed according to the extraction steps in Example 2, the sample solution to be tested was injected, and the sample repeatability was calculated based on the experimental results of 6 times. The results confirmed that the RSDs of the 7 compounds were 0.49%, 0.88%, 1.90%, 1.37%, 3.01%, 3.08%, and 1.37%, respectively, all less than 15.00%, indicating that the sample repeatability was good. The specific results are shown in Table 5.

[0165] Sample recovery rate: Take a sample solution of known concentration, add the compound reference, mix well and repeat the sample loading three times to calculate the sample recovery rate.

[0166] Sample recovery rate % = (actual value - the amount of the measured component contained in the test sample) / the amount of reference substance added × 100%

[0167] The specific results of the sample recovery are shown in Table 6. The results confirmed that the RSDs of the seven compounds were all within 15%, which met the method requirements.

[0168] Example 6 Detection of 7 compounds in samples

[0169] Extraction of Hericium erinaceus mycelium: The strain of Hericium erinaceus is 7080 (strain 1), and the fermentation method is the same as in Example 1. Weigh 0.50 g of dried Hericium erinaceus mycelium, add 10 mL of analytical grade ethanol at a solid-liquid ratio of 1:20 (weight-to-volume ratio, weight g: volume ml), perform ultrasonic extraction for 60 min, and filter the supernatant with an organic phase microporous filter membrane with a pore size of 0.22 μm to obtain a sample solution to be tested.

[0170] Source of Hericium erinaceus fruiting bodies: Hericium erinaceus fruiting bodies were collected from various provinces in China, including HE-1 (Shaoguan, Guangdong), HE-2 (Bijie, Guizhou), HE-3 (Xiangyang, Hubei), HE-4 (Huangshan, Anhui), HE-5 (Lishui, Zhejiang), HE-6 (Jinggangshan, Jiangxi), HE-7 (Lishui, Sichuan), HE-8 (Kunming, Yunnan), HE-9 (Hailin, Heilongjiang), HE-10 (Chifeng, Inner Mongolia), and HE-11 (Baishan, Jilin).

[0171] Extraction of Hericium erinaceus fruiting bodies: Weigh 0.50 g of each dried and crushed Hericium erinaceus fruiting body, add 10 mL of ethanol at a solid-liquid ratio of 1:20 (weight-to-volume ratio, weight g: volume ml), perform ultrasonic extraction for 60 min, and filter the supernatant with an organic phase microporous filter membrane with a pore size of 0.22 μm to obtain the sample solution to be tested.

[0172] Test results: The Hericium erinaceus mycelium test sample solution (strain 1) and the Hericium erinaceus fruiting body test sample solution were tested according to the detection method of Example 4, and the specific test results are shown in Tables 7 and 8.

[0173] Table 2. Intra-day precision results

[0174]

[0175] Table 3. Inter-day precision results

[0176]

[0177] Table 4. Sample stability results

[0178]

[0179] Table 5. Sample repeatability results

[0180]

[0181] Table 6. Sample recovery results

[0182]

[0183] Table 7. Mycelium determination results

[0184]

[0185] Table 8. Quantitative results of Hericium erinaceus fruiting bodies from different origins

[0186]

[0187] Table 9 IC of compounds inhibiting α-glucosidase 50 value

[0188]

Claims

1. Compounds erinacerin X, erinacerin Y and erinacerin Z are respectively Compound 1, Compound 5 and Compound 6 of the following structural formulas:

2. A method for simultaneously detecting seven compounds in Hericium erinaceus, Features The method comprises the following steps: (1) Pretreatment steps of Hericium erinaceus samples: adding ethanol to Hericium erinaceus fruiting bodies or mycelium for ultrasonic extraction or heating extraction at 60° C., taking the supernatant, filtering, and obtaining the filtrate as the sample solution to be tested; preparing a mixed reference solution of 7 compounds; (2) Ultra-high performance liquid chromatography detection step: ultra-high performance liquid chromatography separation of the sample solution and the mixed reference solution of the seven compounds to obtain a better separation degree; (3) Steps for obtaining compound mass spectrometry information: Using the mass spectrometry optimization software Agilent Optimizer, the seven compounds were scanned for parent ions, detected for daughter ion pairs, and searched for the optimal collision energy; (4) Steps for establishing the ultra-high performance liquid chromatography-triple quadrupole mass spectrometry analysis method: In the data acquisition software Agilent MassHunter Data Acquisition, under the ultra-high performance liquid chromatography analysis conditions and triple quadrupole mass spectrometry detection conditions, the retention time, parent ion, daughter ion pair and collision energy data were imported to establish a dynamic multiple reaction DMRM monitoring and analysis method for the seven compounds; at the same time, the mixed reference solution and the sample solution of the seven compounds were loaded and measured; (5) Data analysis step: using the quantitative analysis software Agilent MassHunter Quantitative Analysis, standard curves of seven compounds were created, the method was validated, and the sample solutions were quantitatively analyzed; The 7 compounds described are: Erinacerin 3. The method for simultaneously detecting 7 compounds in Hericium erinaceus according to claim 2, wherein the pretreatment step of the Hericium erinaceus mycelium or fruiting body sample in step (1) is as follows: freeze-drying the sample to be tested, adding ethanol at a solid-liquid ratio of 1:20-1:40, weight g: volume ml, ultrasonic extraction for 10-90 min or heating extraction at 60°C for 10-90 min, and filtering the extract with an organic phase microporous filter membrane with a pore size of 0.22 μm to obtain a sample solution to be tested.

4. The method for simultaneously detecting 7 compounds in Hericium erinaceus according to claim 2, wherein the preparation method of the mixed reference solution of the 7 compounds in step (1) is: take 7 compound reference substances, prepare a mixed standard solution with mass spectrometry grade methanol at a concentration of 5 μg / mL, and then dilute stepwise to obtain mixed standard working solutions of 2 μg / mL, 1 μg / mL, 500 ng / mL, 200 ng / mL, 100 ng / mL, 50 ng / mL, and 20 ng / mL.

5. The method for simultaneously detecting 7 compounds in Hericium erinaceus according to claim 2, wherein the chromatographic conditions for ultra-high performance liquid chromatography separation in step (2) are: Agilent ZORBAX Eclipse Plus C18 chromatographic column, 1.8 μm, 2.1×150 mm; column temperature: 35° C.; sample load: 2 μL; flow rate: 0.4 mL / min; mobile phase A: 0.01% formic acid; mobile phase B: acetonitrile; elution program: 0 min: 80% A, 20% B; 12 min: 75% A, 25% B; 14 min: 63% A, 37% B; 19 min: 55% A, 45% B; 38 min: 10% A, 90% B; 40 min: 0% A, 100% B.

6. The method for simultaneously detecting seven compounds in Hericium erinaceus according to claim 2, wherein the retention time, parent ion, daughter ion pair and collision energy information of each compound required for analysis in step (3) are obtained by mass spectrometry optimization software Agilent Optimizer as follows: Erinacerin X: retention time: 11.65min; parent ion: 279.1; quantitative ion: 245.0, collision energy: 17; qualifier ion: 173.0, collision energy 21; Corallocin A: retention time: 19.98min; parent ion: 345.1; quantitative ion: 300.9, collision energy: 13; qualifier ion: 121.0, collision energy 29; Hericerin A: retention time: 23.27min; parent ion: 358.2; quantitative ion: 274.0, collision energy: 29; qualifier ion: 219.8, collision energy 33; N-De phenylethyl isohericerin: retention time: 23.89min; parent ion: 314.2; quantitative ion: 229.9, collision energy: 29; qualitative ion: 175.9, collision energy 25; Erinacerin Y: retention time: 28.21min; parent ion: 428.2; quantitative ion: 343.9, collision energy: 37; qualifier ion: 297.9, collision energy 37; Erinacerin Z: retention time: 28.87min; parent ion: 414.2; quantitative ion: 340.1, collision energy: 25; qualifier ion: 256.0, collision energy 41; Isohericerin; retention time: 30.41min; parent ion: 418.2; quantitative ion: 334.0, collision energy: 19; qualified ion: 280.0, collision energy 33.

7. The method for simultaneously detecting seven compounds in Hericium erinaceus according to claim 2, wherein in step (4), ultra-high performance liquid chromatography-triple quadrupole mass spectrometry is used as the analytical detection instrument, wherein the chromatographic conditions of ultra-high performance liquid chromatography separation are: Agilent ZORBAX Eclipse Plus C18 chromatographic column, 1.8 μm, 2.1×150 mm; column temperature: 35° C.; sample load: 2 μL; flow rate: 0.4 mL / min; mobile phase A: 0.01% formic acid; mobile phase B: acetonitrile; elution program: 0 min: 80% A, 20% B; 12 min: 75% A, 25% B; 14 min: 63% A, 37% B; 19 min: 55% A, 45% B; 38 min: 10% A, 90% B; 40 min: 0% A, 100% B; mass spectrometry conditions: electrospray ionization source AJS ESI was used as the ion source and the detection was carried out in the negative ion mode. Dynamic multiple reaction monitoring (DMRM) was selected. The capillary voltage was 3500 V, the capillary outlet voltage was 380 V, the nozzle voltage was 2000 V, the dryer temperature and flow rate were 200 °C and 16 L / min, respectively, and the sheath gas temperature and flow rate were 350 °C and 12 L / min, respectively.

Citation Information

Patent Citations

  • Hericium erinaceus isolate and isolating method and application thereof

    CN104530073A

  • Method for simultaneously detecting 12 triterpenoids in ganoderma sinensis mycelia

    CN116429929A

  • Method for simultaneously detecting 13 triterpenoids in ganoderma tsugae mycelium

    CN117949576A